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dominant disorders, NF1. Loss of the NF1 protein product,
neurofibromin, is associated with benign neurofibromas,
comprised largely of Schwann Cells (SC). The number and
severity of neurofibromas increase during times of high
hormonal activity, including puberty and pregnancy, and may
regress after childbirth. Mouse embryonic stem cells (mESC)
that are NF1 wild type, heterozygous, or null can be
differentiated into SC-like cells, which express SC and
myelination markers. Two human NF1 tumor cell lines, one
from a benign plexiform neurofibroma and one from a
malignant peripheral nerve sheath tumor (MPNST) cell line,
have also been shown to become Schwann-like cells in culture.
We have used this model system to study the proliferation of
these SC-like cells expressing various levels of neurofibromin,
to differing levels of the hormones that increase during
pregnancy: progesterone (P4), estrogen (E2), or testosterone
(T), with and without their respective receptor inhibitors
(RU486, ICI182780, Flutamide). We have also found that an
E2 metabolite, 2-Methoxyestradiol (2ME2), which has been
found to kill many types of tumor cells, is cytotoxic to the
NF1/ malignant tumor cell line, while it inhibits prolifer-
ation in the other cell lines. 2ME2 could also provide a new
treatment avenue for NF1 tumors sensitive to hormones at
times of greatest hormonal influence on tumor growth.
doi:10.1016/j.ydbio.2006.04.085
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Vertebrate islet has four major cell types: a, b, d and PP-
cells, producing glucagon, insulin, somatostatin and pancreatic
polypeptide, respectively. Myt1 transcription factor is specif-
ically expressed in endocrine progenitors. Previous over-
expression and gene knockdown results suggested that Myt1
is involved in endocrine islet differentiation. To verify these
findings, we performed gene targeting to knock out Myt1.
Global Myt1/ mice die immediately after birth. Their
pancreata do not exhibit prominent defects. Yet double
immuno-labeling revealed abnormal co-expression of several
hormones in islet cells in these mutants, suggesting that Myt1
is required for endocrine differentiation. In order to assess
whether these early defects have any functional consequences,
we generated pancreatic specific Myt1 mutants using a Cre–
Lox-mediated gene inactivation approach. Intraperitoneal
glucose tolerance tests showed that the pancreatic specific
Myt1 knockout male mice were diabetic. Serum insulin
secretion test further revealed an impairment of insulin
secretion. Consistent with this diabetic phenotype, the expres-
sion level of Glut2, an important glucose sensor, was
significantly reduced in the mutant pancreata. Because Myt1
expression is also detected in adult endocrine islets, we
examined whether Myt1 function is required for adult islet
function maintenance. We find that loss of Myt1 function in
adult male mice results in diabetes. These findings suggested
that Myt1 is required for both islet cell differentiation during
embryogenesis and islet maintenance in adult mice.
doi:10.1016/j.ydbio.2006.04.086
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The Wnt/b-catenin signaling pathway has emerged as a key
regulator in bone development and bone homeostasis. Loss-of-
function mutations in the Wnt co-receptor Low-density
lipoprotein receptor-related protein 5 (LRP5) result in osteo-
porosis and gain-of-function mutations in LRP5 result in high
bone mass. Dickkopf-1 (Dkk1) is a secreted Wnt inhibitor that
binds LRP5 and LRP6, reducing their availability to form a
complex with Wnt and Frizzled. Therefore, it is expected that a
decrease in Dkk1 will result in an increase in Wnt activity and a
high bone mass phenotype. Dkk1/ knockout mice are
embryonic lethal, but by crossing null and hypomorphic Dkk1
alleles we are able to produce mice expressing low amounts of
Dkk1 that survive to adulthood. In this study we have
generated an allelic series of Dkk1 mutant mice to examine
how reduced Dkk1 levels affect bone density. Using microCT
imaging, we have scanned dissected femura and calvariae to
analyze bone mineral density in trabecular and cortical regions.
Our preliminary data suggest that Dkk1 mutant mice display a
high bone mass phenotype that is inversely proportional to
Dkk1 expression level. To ascertain the mechanism for this
phenotype, we will isolate bone marrow stromal osteoblasts
and osteoclasts from Dkk1 mutant mice and analyze their
activity in cell culture.
doi:10.1016/j.ydbio.2006.04.087
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